Search Results

Regulation (EU) 2021/2282 of the European Parliament and of the Council of 15 December 2021 on health technology assessment and amending Directive 2011/24/EU (Text with EEA relevance)

PE/80/2021/INIT

OJ L 458, 22.12.2021, pp. 1–32 (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ L 458, 22.12.2021, pp. 1–32

Non-opposition to a notified concentration (Case M.10813 – BLACKSTONE / CPP INVESTMENTS / ADVARRA) (Text with EEA relevance) 2023/C 230/01

C/2022/5997

OJ C 230, 30.6.2023, pp. 1–1 (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 230, 30.6.2023, pp. 1–1

Prior notification of a concentration (Case M.10813 – BLACKSTONE / CPP INVESTMENTS / ADVARRA) Candidate case for simplified procedure (Text with EEA relevance) 2022/C 287/06

PUB/2022/924

OJ C 287, 28.7.2022, pp. 81–82 (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 287, 28.7.2022, pp. 81–82

Commission Decision (EU) 2021/1240 of 13 July 2021 on the compliance of the EU portal and the EU database for clinical trials of medicinal products for human use with the requirements referred to in Article 82(2) of Regulation (EU) No 536/2014 of the European Parliament and of the Council (Text with EEA relevance)

C/2021/5063

OJ L 275, 31.7.2021, pp. 1–2 (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ L 275, 31.7.2021, pp. 1–2

Non-opposition to a notified concentration (Case M.10278 — EQT/Cerba) (Text with EEA relevance) 2021/C 244/02

C/2021/4350

OJ C 244, 22.6.2021, pp. 2–2 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 244, 22.6.2021, pp. 2–2

Prior notification of a concentration (Case M.10278 – EQT/Cerba) Candidate case for simplified procedure (Text with EEA relevance) 2021/C 201/12

PUB/2021/408

OJ C 201, 28.5.2021, pp. 15–15 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 201, 28.5.2021, pp. 15–15

Case T-309/25: Action brought on 13 May 2025 – SCM Biogroup v EUIPO – Bio Group Medical System (BIO-GROUP MEDICAL SYSTEM)

OJ C, C/2025/3552, 7.7.2025, ELI: http://data.europa.eu/eli/C/2025/3552/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C, C/2025/3552, 7.7.2025, ELI: http://data.europa.eu/eli/C/2025/3552/oj

Case T-786/22: Action brought on 18 December 2022 — Frajese v Commission

OJ C 63, 20.2.2023, pp. 58–59 (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 63, 20.2.2023, pp. 58–59

Non-opposition to a notified concentration (Case M.10454 – OMERS / GOLDMAN SACHS / AMEDES) (Text with EEA relevance) 2021/C 446/01

C/2021/7786

OJ C 446, 3.11.2021, pp. 1–1 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 446, 3.11.2021, pp. 1–1

Prior notification of a concentration (Case M.10454 – Omers/Goldman Sachs/Amedes) Candidate case for simplified procedure (Text with EEA relevance) 2021/C 411/05

PUB/2021/801

OJ C 411, 11.10.2021, pp. 6–7 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 411, 11.10.2021, pp. 6–7